FDA Orange Book
Generic for Vaseretic
Vaseretic contains enalapril and hydrochlorothiazide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Vaseretic is enalapril and hydrochlorothiazide. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Vaseretic and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vaseretic products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 10MG;25MG | Marketed (Rx) | AB | 2 | AB |
| tablet, oral | 5MG;12.5MG | Marketed (Rx) | AB | 2 | AB |
NDA 019221, held by BAUSCH HEALTH US LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic enalapril and hydrochlorothiazide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD | 075788 | AB (A-rated, therapeutically equivalent) | September 18, 2001 | 10MG;25MG, 5MG;12.5MG |
| PHARMAZONE | 075909 | AB (A-rated, therapeutically equivalent) | October 15, 2001 | 10MG;25MG, 5MG;12.5MG |
Vaseretic NDC codes
Questions
Is there a generic for Vaseretic?
Yes. The generic name for Vaseretic is enalapril and hydrochlorothiazide. 2 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Vaseretic?
The active ingredient in Vaseretic is enalapril and hydrochlorothiazide, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.